BAD and cancer: In addition, it was reported that the phosphorylation status of the B-cell lymphoma 2 (Bcl-2)-associated death promoter (BAD) protein and BAD-mediated apoptotic pathway influenced the chemosensitivity of cancer cells and was associated with the development of cancers, including ovarian, breast, and colon cancer [34–36].